Login to Your Account

Clinic Roundup

Wednesday, May 29, 2013

• Reneuron plc, of Guildford, UK, provided an update on progress with the PISCES trial of its ReN001 stem cell therapy for disabled stroke patients. Interim data from the first nine patients treated in the PISCES study are being presented by the clinical team from Glasgow's Southern General Hospital at the 22nd European Stroke Conference, taking place in London this week.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription